This category is used for all new drugs that is recently approved by United States Food And Drugs Administration (FDA).
Dovato is a recently approved HIV/AIDS medicine. It is the brand name for the two antiretroviral medications (Dolutegravir and Lamivudine) to treat Human Immunodeficiency Virus-1 (HIV-1)/AIDs in adults and in children aged above 12 years. Dovato is the first once-daily, two-drugs, single tablet, and complete regime approved by the US Food and Drugs Administration (FDA) …
Dovato: Uses, Side Effects, Precautions, Dosage & FAQs Read More »
The US food and drug administration has recently approved a combination therapy (Opdivo and Yervoy) to treat adults with unresectable malignant pleural mesothelioma. This is the first combo drug approval for mesothelioma in 16 years. Mesothelioma is a rare and aggressive type of cancer that is caused by inhaling asbestos. Opdivo and Yervoy Opdivo (nivolumab) …
FDA Approves (Opdivo and Yervoy) for Treating Mesothelioma Read More »
The report on Lonsurf was published on the official website of U.S Food and Drug Administration. Gastric adenocarcinoma is a type of stomach cancer and is considered the second most common cancer in the world. According to reports, the combined drug Lonsurf can cure those patients who are suffering from gastric adenocarcinoma. Gastric cancer is …
FDA Approved a Combo Drug (Lonsurf) for Gastric Cancer Read More »
Researchers at the Koch Institute have created a blueberry-sized capsule that can be used to administer oral insulin doses. It can replace the injections that people with type 2 diabetes should give up every day. Insulin is a peptide hormone produced by the β-cells of the pancreas. This enables the body to regulate the amount of …
New Oral Capsule can deliver insulin through microneedles in the stomach Read More »
A new drug from Zion Medical named—Gammora claims to kill 99 % of the HIV virus during the first human trial. The therapy was made to kill HIV-infected cells without damaging uninfected ones. Compared to current antiretroviral medications that only suppress the spread of this virus, Gammora provides hope that a real cure may one …
Does Gammora Really Kills 99% Of HIV/Aids Virus? Read More »
Epidiolex, the very first cannabis-based drug approved by the US Food and Drug Administration, is currently available by prescription in all 50 states. It was found in 1940 and originally thought to not be pharmaceutically active. It’s one of 113 cannabinoids found in hemp plants, accounting for as many as 40 percent of the plant …
FDA-approved First cannabis-based drug (Epidiolex) For Epilepsy Read More »
The Food and Drug Administration approved a Brand New flu Medicine on Wednesday Called Xofluza. The drug is given as one dose and might lessen the duration of influenza symptoms by about a day. A exceptional characteristic about XOFLUZA, in comparison to neuroaminidase inhibitors such as Tamiflu and Relenza, is that you simply take one …
The FDA Approves a Game Changer Flu Drug (Xofluza) Read More »
The FDA announced it has given Insmed, Inc. approval for Arikayce, a brand new drug developed for the treatment of lung disorder brought on by Mycobacterium avium complicated. “As bacteria continue to develop to currently available antibiotics, we must promote the development of drugs which may treat resistant infections,” FDA Commissioner Scott Gottlieb, MD, stated …
FDA Clears New Antibiotic Arikayce for Lung Disease Read More »
The new medication is named Emgality (Galcanezumab) and can be used particularly to stop migraines,and it is manufactured by drug giant Eli Lilly. The medication has a record price of $575 per month, approximately $6,900 annually. Until May, there were not any drugs available now which were initially approved for relieving migraines, even however other …
FDA Approves A New Drug (Galcanezumab) For Migraine Treatment Read More »
There was positive news now for Germany’s biggest pharma firm, with acceptance for its most recent hemophilia A medication in the united states, which will offer a near term boost for its hemophilia portfolio. The Biologics License Application was filed with the bureau in October this past year. Jivi is a recombinant factor VIII (rFVIII) …